Production Delays in Dental Restorative Materials Following the Launch of MMG’s New Headquarters and Plant
First written in FY2024-Q1. 2 of 8 entries say "Mitigated", first in FY2024-Q2. Latest entry: 2026-10-15.
2 other companies' latest entry also says "Mitigated".
- 2026-10-15MitigatedEarnings
「セグメント利益は、中国におけるダイヤバー再販売による増収効果に加え、売上総利益率の改善が寄与し、前期から大幅に回復しました。」
MMGを含むデンタル関連製品の収益性について、前期の減損発生後、デンタル関連製品全体では利益が大幅に回復している。 - FY2026-H1ReframedAnnual report
「As part of efforts to rebuild the performance of German subsidiary MMG, the company decided to implement the 3 reforms described below. It aims to strengthen the competitiveness and achieve sustainable growth of its dental business in Europe.」
The focus has expanded from recognizing the problem of sluggish sales following the launch of MMG's new headquarters and plant to rebuilding performance through the selection and concentration of OEM operations, the development of proprietary brands, and the establishment of a European sales base for MANI dental products. - FY2025MaterialisedAnnual report
「Sales of German MMG products, primarily dental restorative materials, remained sluggish in Europe. … An impairment loss of ¥1,190 million on MMG's property, plant and equipment was recorded as an extraordinary loss.」
Continued sluggish sales of MMG products resulted in an actual accounting impact in the form of a ¥1,190 million impairment loss on property, plant and equipment due to declining profitability. - FY2025-H1RestatedAnnual report
「Sales of German MMG products, primarily dental restorative materials, remained sluggish, particularly in Europe.」
The company stated that sales of MMG products, primarily dental restorative materials, have remained sluggish even after the previous period, when it disclosed that production delays following the launch of MMG's new headquarters and plant had been resolved. - FY2024RestatedAnnual report
「Sales of German MMG products, primarily dental restorative materials, remained sluggish.」
Compared with the resolution of production delays and the recovery trend following the launch of MMG's new headquarters and plant described in the previous quarter, the full-year disclosure again described sluggish sales of MMG products, primarily dental restorative materials. - FY2024-Q3WorsenedAnnual report
「Sales of MMG products, primarily dental restorative materials, remained sluggish in the third quarter.」
The previous quarter described the resolution of production delays at MMG's new headquarters and plant and a trend toward recovery in sales, whereas the third quarter described sluggish sales of MMG products, primarily dental restorative materials. - FY2024-Q2MitigatedAnnual report
「In addition, production delays that occurred at the new headquarters and plant of MMG, the consolidated German subsidiary, in the previous quarter have been resolved, and production has returned to normal levels. As a result, sales of MMG products, mainly dental restorative materials, are trending higher than in the previous quarter.」
Production delays associated with the launch of MMG's new headquarters and plant, which occurred in the previous quarter, were resolved, and production and sales began to recover. - FY2024-Q1First statedAnnual report
「Sales of MMG products, primarily dental restorative materials, remained sluggish due to production delays at German consolidated subsidiary MMG following the launch of its new headquarters and plant.」
Production delays actually occurred following the launch of MMG's new headquarters and plant, and this was disclosed as sluggish sales of MMG products, primarily dental restorative materials.